ConductScience.org, home

Paper33536615

IgA transcytosis and antigen recognition govern ovarian cancer immunity.

Biswas S and 22 others. Nature, 2021. Cited by 207 papers, by iCite.

Cite this record

ConductScience Library. IgA transcytosis and antigen recognition govern ovarian cancer immunity. Papers, record 33536615. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33536615

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
IgA transcytosis and antigen recognition govern ovarian cancer immunity.
PubMed
Journal
Nature
PubMed
Year
2021
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
207
iCite
Relative citation ratio, by iCite
9.59
iCite
Revised in PubMed
2026-11-02
PubMed

Authors23

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Biswas SSubir
2Mandal GGunjan
3Payne KKKyle K
4Anadon CMCarmen Mhttps://orcid.org/0000-0002-8851-4545
5Gatenbee CDChandler Dhttps://orcid.org/0000-0002-9730-5964
6Chaurio RARicardo A
7Costich TLTara Lee
8Moran CCarlos
9Harro CMCarly M
10Rigolizzo KEKristen Ehttps://orcid.org/0000-0003-0222-0683
11Mine JAJessica A
12Trillo-Tinoco JJimena
13Sasamoto NNaokohttps://orcid.org/0000-0002-4526-2181
14Terry KLKathryn L
15Marchion DDouglas
16Buras AAndrea
17Wenham RMRobert M
18Yu XXiaoqing
19Townsend MKMary K
20Tworoger SSShelley S

Source PubMed

See all 23 authorsDownload CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antigens, NeoplasmMajor topic
Immunoglobulin AMajor topic
Ovarian NeoplasmsMajor topic
T-Lymphocytes, CytotoxicMajor topic
TranscytosisMajor topic
Antibody Specificity
Antigens, CD
Cell Line
Disease Progression
Female
Humans
Receptors, Fc
Signaling Lymphocytic Activation Molecule Family
Tumor Microenvironment

Source PubMed

Download CSV of topics

Grants17

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R01 CA233512NCI NIH HHSUnited StatesR01CA233512PubMedNIH RePORTER
UM1 CA186107NCI NIH HHSUnited StatesUM1CA186107PubMed and NIHNIH RePORTER
R01 CA157664NCI NIH HHSUnited StatesR01CA157664PubMed and NIHNIH RePORTER
R01 CA262121NCI NIH HHSUnited StatesR01CA262121PubMedNIH RePORTER
U01 CA232758NCI NIH HHSUnited StatesU01CA232758PubMed and NIHNIH RePORTER
U01 CA176726NCI NIH HHSUnited StatesU01CA176726PubMed and NIHNIH RePORTER
T32 CA009140NCI NIH HHSUnited StatesT32CA009140PubMed and NIHNIH RePORTER
P01 CA250984NCI NIH HHSUnited StatesP01CA250984PubMedNIH RePORTER
R01 CA124515NCI NIH HHSUnited StatesR01CA124515PubMed and NIHNIH RePORTER
R01 CA184185NCI NIH HHSUnited StatesR01CA184185PubMed and NIHNIH RePORTER
P01CA087969NIHNIH RePORTER
P30CA076292NIHNIH RePORTER
R01CA054419NIHNIH RePORTER
R01CA178687NIHNIH RePORTER
R01CA211913NIHNIH RePORTER
R35CA197605NIHNIH RePORTER
UM1CA176726NIHNIH RePORTER

Download CSV of grants

Comments and corrections2

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn PapersSource
Comment in33627799IgA strikes twice in ovarian cancer.https://conductscience.org/library/papers/33627799PubMed
Comment in33974859IgA transcytosis: A new weapon in the immune response to cancer?https://conductscience.org/library/papers/33974859PubMed

Download CSV of comments and corrections

Cited by159

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 207 citations.

PMIDTitleJournalYearIn PapersSource
42856194BLTP3A dysfunction unleashes lysosomal stress-induced antitumor immunity through STING.bioRxiv2026https://conductscience.org/library/papers/42856194PubMed
42846924The multifaceted roles of tumor-infiltrating plasma cells in cancer immunology.Fundam Res2026https://conductscience.org/library/papers/42846924PubMed
42824425Why antibody isotype matters for immunotherapy.Antib Ther2026https://conductscience.org/library/papers/42824425PubMed
42776800B Cells and Tumor Immunometabolism: Emerging Insights into Immune Regulation and Therapeutic Resistance.Antibodies (Basel)2026https://conductscience.org/library/papers/42776800PubMed
42764955CMTM6 maintains B cell-intrinsic membrane CD40 stability to regulate anti-tumor immunity.Acta Pharm Sin B2026https://conductscience.org/library/papers/42764955PubMed
42735911Spatiotemporal immune heterogeneity and precision immunotherapy for ovarian cancer.Clin Transl Med2026https://conductscience.org/library/papers/42735911PubMed
42706236B cells in cancer: functions, mechanisms and therapeutic advances.Signal Transduct Target Ther2026https://conductscience.org/library/papers/42706236PubMed
42597660B cell receptor-based hybridoma enrichment enables discovery of antibodies against intracellular tumor antigens.Front Immunol2026https://conductscience.org/library/papers/42597660PubMed
42472098Isotype-switched antibodies originating from tertiary lymphoid structures can antagonize ovarian cancer progression.iScience2026https://conductscience.org/library/papers/42472098PubMed
42456977Strategic engineering B cell immunity for cancer immunotherapy.J Control Release2026https://conductscience.org/library/papers/42456977PubMed
42414574Retargeted adenoviruses for local IgA and CD47 blocker production as a novel cancer therapy.EMBO Mol Med2026https://conductscience.org/library/papers/42414574PubMed
42380095Advances and prospects in cell therapy for cancer: explorations from T cells to stem cells.Signal Transduct Target Ther2026https://conductscience.org/library/papers/42380095PubMed
42299115Glioma microenvironment: Cellular crosstalk, immunosuppression, and novel therapeutic perspectives.Chin Med J (Engl)2026https://conductscience.org/library/papers/42299115PubMed
42291273Tumor infiltrating B cells and tertiary lymphoid structures in pancreatic cancer prognosis and therapy.iScience2026https://conductscience.org/library/papers/42291273PubMed
42100745Integrated study reveals molecular mechanisms by which bisphenol A promotes ovarian cancer.iScience2026https://conductscience.org/library/papers/42100745PubMed
42097835Endogenous neoantigen-specific antibodies mediate antitumor responses and determine vaccine efficacy.J Immunother Cancer2026https://conductscience.org/library/papers/42097835PubMed
42091692Defining the rules of engagement: B cells, antibodies and cancer control.Cell Mol Immunol2026https://conductscience.org/library/papers/42091692PubMed
41998137Neoantigens and shared MICB α3 antigen dual-targeted vaccine generates potent antitumor immunity.EMBO Mol Med2026https://conductscience.org/library/papers/41998137PubMed
41975230Rethinking ovarian cancer III: the past decade and future directions.Nat Rev Cancer2026https://conductscience.org/library/papers/41975230PubMed
41922487Mapping immunosuppressive terrain in high-grade serous ovarian cancer: tumor-intrinsic, stromal, and spatial drivers of therapy response.NPJ Precis Oncol2026https://conductscience.org/library/papers/41922487PubMed

See all 159 cited byDownload CSV of cited by

Genes32

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ANXA5308PubTator's text mininghttps://conductscience.org/library/genes/308NCBI Gene
APC324PubTator's text mininghttps://conductscience.org/library/genes/324NCBI Gene
BCR613PubTator's text mininghttps://conductscience.org/library/genes/613NCBI Gene
BDNF627PubTator's text mininghttps://conductscience.org/library/genes/627NCBI Gene
CD19930PubTator's text mininghttps://conductscience.org/library/genes/930NCBI Gene
CD27939PubTator's text mininghttps://conductscience.org/library/genes/939NCBI Gene
CD38952PubTator's text mininghttps://conductscience.org/library/genes/952NCBI Gene
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920NCBI Gene
CD79A973PubTator's text mininghttps://conductscience.org/library/genes/973NCBI Gene
CD8A925PubTator's text mininghttps://conductscience.org/library/genes/925NCBI Gene
CST12P106478911PubTator's text mininghttps://conductscience.org/library/genes/106478911NCBI Gene
CTAG1A246100PubTator's text mininghttps://conductscience.org/library/genes/246100NCBI Gene
DUSP51847PubTator's text mininghttps://conductscience.org/library/genes/1847NCBI Gene
EPCAM4072PubTator's text mininghttps://conductscience.org/library/genes/4072NCBI Gene
FCAMR83953PubTator's text mininghttps://conductscience.org/library/genes/83953NCBI Gene
FSHR2492PubTator's text mininghttps://conductscience.org/library/genes/2492NCBI Gene
IGH3492PubTator's text mininghttps://conductscience.org/library/genes/3492NCBI Gene
IGHA13493PubTator's text mininghttps://conductscience.org/library/genes/3493NCBI Gene
ITGAM3684PubTator's text mininghttps://conductscience.org/library/genes/3684NCBI Gene
KRT2054474PubTator's text mininghttps://conductscience.org/library/genes/54474NCBI Gene

See all 32 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/33536615

GET https://conductscience.org/api/papers/v1/33536615/authors?page=2